High Court Refuses To Hear Authorized Generics Suit
The U.S. Supreme Court on Monday refused to hear the tamoxifen citrate antitrust lawsuit, meaning it will not weigh in on the legal issues surrounding authorized generics....To view the full article, register now.
Already a subscriber? Click here to view full article